Global Opioid Induced Constipation (OIC) Drugs Market Size, Share, Trends and Forecast 2021-2027

Description

The global Opioid Induced Constipation (OIC) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
Global Opioid Induced Constipation (OIC) Drugs Scope and Segment
Opioid Induced Constipation (OIC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Opioid Induced Constipation (OIC) Drugs Breakdown Data by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Opioid Induced Constipation (OIC) Drugs Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Opioid Induced Constipation (OIC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Opioid Induced Constipation (OIC) Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Opioid Induced Constipation (OIC) Drugs Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market by Application
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Opioid Induced Constipation (OIC) Drugs Regions by Sales
2.4.1 Global Top Opioid Induced Constipation (OIC) Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Opioid Induced Constipation (OIC) Drugs Regions by Sales (2022-2027)
2.5 Global Top Opioid Induced Constipation (OIC) Drugs Regions by Revenue
2.5.1 Global Top Opioid Induced Constipation (OIC) Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Opioid Induced Constipation (OIC) Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers
3.1.1 Global Top Opioid Induced Constipation (OIC) Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Opioid Induced Constipation (OIC) Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drugs Sales in 2020
3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers
3.2.1 Global Top Opioid Induced Constipation (OIC) Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Opioid Induced Constipation (OIC) Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drugs Revenue in 2020
3.3 Global Opioid Induced Constipation (OIC) Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Opioid Induced Constipation (OIC) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2016-2027)
4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type
4.2.1 Global Opioid Induced Constipation (OIC) Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Opioid Induced Constipation (OIC) Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type
4.3.1 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2016-2021)
4.3.2 Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application
5.1.1 Global Opioid Induced Constipation (OIC) Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Opioid Induced Constipation (OIC) Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2016-2027)
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application
5.2.1 Global Opioid Induced Constipation (OIC) Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Opioid Induced Constipation (OIC) Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application
5.3.1 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2016-2021)
5.3.2 Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Opioid Induced Constipation (OIC) Drugs Market Size by Type
6.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Type (2016-2027)
6.1.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Type (2016-2027)
6.2 North America Opioid Induced Constipation (OIC) Drugs Market Size by Application
6.2.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Application (2016-2027)
6.2.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Application (2016-2027)
6.3 North America Opioid Induced Constipation (OIC) Drugs Market Size by Country
6.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2016-2027)
6.3.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Type
7.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2027)
7.1.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Type (2017-2027)
7.2 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Application
7.2.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Application (2017-2027)
7.2.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Application (2017-2027)
7.3 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Country
7.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2027)
7.3.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Type
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Application
8.2.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Region
8.3.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Opioid Induced Constipation (OIC) Drugs Market Size by Type
9.1.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Type (2019-2027)
9.1.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Type (2019-2027)
9.2 Latin America Opioid Induced Constipation (OIC) Drugs Market Size by Application
9.2.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Application (2019-2027)
9.2.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Application (2019-2027)
9.3 Latin America Opioid Induced Constipation (OIC) Drugs Market Size by Country
9.3.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2019-2027)
9.3.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size by Type
6.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size by Application
6.2.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size by Country
6.3.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Ironwood Pharmaceuticals Inc
11.1.1 Ironwood Pharmaceuticals Inc Corporation Information
11.1.2 Ironwood Pharmaceuticals Inc Overview
11.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Description
11.1.5 Ironwood Pharmaceuticals Inc Related Developments
11.2 Daiichi Sankyo Co Ltd
11.2.1 Daiichi Sankyo Co Ltd Corporation Information
11.2.2 Daiichi Sankyo Co Ltd Overview
11.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Description
11.2.5 Daiichi Sankyo Co Ltd Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Product Description
11.3.5 Pfizer Related Developments
11.4 Progenics Pharmaceuticals Inc
11.4.1 Progenics Pharmaceuticals Inc Corporation Information
11.4.2 Progenics Pharmaceuticals Inc Overview
11.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Description
11.4.5 Progenics Pharmaceuticals Inc Related Developments
11.5 Shionogi & Co., Ltd
11.5.1 Shionogi & Co., Ltd Corporation Information
11.5.2 Shionogi & Co., Ltd Overview
11.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Description
11.5.5 Shionogi & Co., Ltd Related Developments
11.6 Allergan Plc
11.6.1 Allergan Plc Corporation Information
11.6.2 Allergan Plc Overview
11.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Description
11.6.5 Allergan Plc Related Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Corporation Information
11.7.2 Nektar Therapeutics Overview
11.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Description
11.7.5 Nektar Therapeutics Related Developments
11.8 Purdue Pharma
11.8.1 Purdue Pharma Corporation Information
11.8.2 Purdue Pharma Overview
11.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Description
11.8.5 Purdue Pharma Related Developments
11.9 S.L.A. Pharma AG
11.9.1 S.L.A. Pharma AG Corporation Information
11.9.2 S.L.A. Pharma AG Overview
11.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Description
11.9.5 S.L.A. Pharma AG Related Developments
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Corporation Information
11.10.2 Mundipharma International Limited Overview
11.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Description
11.10.5 Mundipharma International Limited Related Developments
11.1 Ironwood Pharmaceuticals Inc
11.1.1 Ironwood Pharmaceuticals Inc Corporation Information
11.1.2 Ironwood Pharmaceuticals Inc Overview
11.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Description
11.1.5 Ironwood Pharmaceuticals Inc Related Developments
11.12 Takeda Pharmaceutical Company Limited
11.12.1 Takeda Pharmaceutical Company Limited Corporation Information
11.12.2 Takeda Pharmaceutical Company Limited Overview
11.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Takeda Pharmaceutical Company Limited Product Description
11.12.5 Takeda Pharmaceutical Company Limited Related Developments
11.13 Theravance Biopharma Inc
11.13.1 Theravance Biopharma Inc Corporation Information
11.13.2 Theravance Biopharma Inc Overview
11.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Theravance Biopharma Inc Product Description
11.13.5 Theravance Biopharma Inc Related Developments
11.14 Bausch Health
11.14.1 Bausch Health Corporation Information
11.14.2 Bausch Health Overview
11.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Bausch Health Product Description
11.14.5 Bausch Health Related Developments
11.15 Cosmo Pharmaceuticals SA
11.15.1 Cosmo Pharmaceuticals SA Corporation Information
11.15.2 Cosmo Pharmaceuticals SA Overview
11.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Cosmo Pharmaceuticals SA Product Description
11.15.5 Cosmo Pharmaceuticals SA Related Developments
11.16 Daewoong Pharmaceutical
11.16.1 Daewoong Pharmaceutical Corporation Information
11.16.2 Daewoong Pharmaceutical Overview
11.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Daewoong Pharmaceutical Product Description
11.16.5 Daewoong Pharmaceutical Related Developments
11.17 C.B. Fleet Company
11.17.1 C.B. Fleet Company Corporation Information
11.17.2 C.B. Fleet Company Overview
11.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 C.B. Fleet Company Product Description
11.17.5 C.B. Fleet Company Related Developments
11.18 Sucampo Pharmaceuticals
11.18.1 Sucampo Pharmaceuticals Corporation Information
11.18.2 Sucampo Pharmaceuticals Overview
11.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 Sucampo Pharmaceuticals Product Description
11.18.5 Sucampo Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Opioid Induced Constipation (OIC) Drugs Value Chain Analysis
12.2 Opioid Induced Constipation (OIC) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioid Induced Constipation (OIC) Drugs Production Mode & Process
12.4 Opioid Induced Constipation (OIC) Drugs Sales and Marketing
12.4.1 Opioid Induced Constipation (OIC) Drugs Sales Channels
12.4.2 Opioid Induced Constipation (OIC) Drugs Distributors
12.5 Opioid Induced Constipation (OIC) Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
13.2 Opioid Induced Constipation (OIC) Drugs Market Drivers
13.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
13.4 Opioid Induced Constipation (OIC) Drugs Market Restraints

14 Key Findings in The Global Opioid Induced Constipation (OIC) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample